Patient engagement was a common theme at this year’s Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT). In this video, Hélène Schoemans, MD, University of Leuven, Leuven, Belgium, discusses the involvement of patient advocacy groups during the patient, family and donor day of EBMT. Finally, Dr Schoemans touches on how unified approaches can aid advances in science. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.
Dr Hélène Schoemans, MD, has participated in advisory boards for Incyte, Janssen, and Novartis; has received speaker’s fees from Novartis, Incyte, Jazz Pharmaceuticals, the Belgian Hematological Society (BHS) and Takeda; has received travel grants from AbbVie, Celgene, CIBMTR, EBMT, Gilead and Incyte, has received research funding from Novartis and the BHS; and has volunteered for the BHS, the CIBMTR, EBMT, and EUPATI.